Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification
2025 · Blood Cancer Journal · 9 citations
https://doi.org/10.1038/s41408-025-01235-7
J
Jürgen Thiele
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.4K
Citations
19
h-index
25
i10-index
Jürgen Thiele is an academic researcher. The author has contributed to research in topics: Anaerobic Digestion and Biogas Production & Biofuel production and bioconversion & Microbial bioremediation and biosurfactants. The author has an h-index of 19, co-authored 39 publications.
Papers by this author
worksLong-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
2018 · Journal of Hematology & Oncology · 81 citations
https://doi.org/10.1186/s13045-018-0585-5
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
2015 · Journal of Translational Medicine · 42 citations
https://doi.org/10.1186/s12967-015-0644-4
The new WHO classification for essential thrombocythemia calls for revision of available evidences
2020 · Blood Cancer Journal · 25 citations
https://doi.org/10.1038/s41408-020-0290-9
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
2022 · Blood · 2,486 citations
https://doi.org/10.1182/blood.2022015850
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat